Evidence for Neurotoxic Activity of Tat from Human Immunodeficiency Virus Type 1

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1991 Feb 1

PMID 1898974

Citations 113

Authors

J M Sabatier

E Vives

K Mabrouk

A Benjouad

H Rochat

A Duval

B Hue

E Bahraoui

Affiliations

Soon will be listed here.

Abstract

The human immunodeficiency virus (HIV) genome codes for a trans-activating regulatory protein, tat. Using chemically synthesized tat, it was found that 125I-tat and 125I-tat38-86 specifically bound to rat brain synaptosomal membranes with moderate affinity (K0.5 = 3 microM). Interaction of tat with nerve cells was also revealed by flow cytometry, which showed its binding to rat glioma and murine neuroblastoma cells, using both direct fluorescence with fluorescein isothiocyanate-labeled tat and indirect immunofluorescence assays. This interaction was investigated with electrophysiology using isolated excitable frog muscle fibers and cockroach giant interneuron synapses. tat acted on the cell membrane and induced a large depolarization, accompanied by a decrease in membrane resistance, thereby modifying cell permeability. The neurotoxicity of tat was further demonstrated in vitro, on glioma and neuroblastoma cell growth, as well as by a 51Cr release assay in both tumor cell lines. Interestingly, no hemolytic activity of tat for human erythrocytes was found even when tat was tested at its highly neurotoxic concentration. Experiments in vivo showed that synthetic tat is a potent and lethal neurotoxic agent in mice. The use of tat peptide derivatives showed that basic region from 49 to 57 is necessary and sufficient for binding to cell membranes and toxicity.

Citing Articles

Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery.

Madadi A, Sohn M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204177 PMC: 11357388. DOI: 10.3390/ph17081070.

Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.

Yadav-Samudrala B, Gorman B, Barmada K, Ravula H, Huguely C, Wallace E Front Neurosci. 2024; 18:1358555.

PMID: 38505774 PMC: 10949733. DOI: 10.3389/fnins.2024.1358555.

Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.

Namba M, Xie Q, Barker J Brain Behav Immun. 2023; 113:453-475.

PMID: 37567486 PMC: 10528352. DOI: 10.1016/j.bbi.2023.07.021.

17⍺-Estradiol Protects against HIV-1 Tat-Induced Endolysosome Dysfunction and Dendritic Impairments in Neurons.

Datta G, Miller N, Chen X Cells. 2023; 12(5).

PMID: 36899948 PMC: 10000619. DOI: 10.3390/cells12050813.

HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in NeuroHIV.

Kannan M, Singh S, Chemparathy D, Oladapo A, Gawande D, Dravid S Extracell Vesicles Circ Nucl Acids. 2023; 3(2):133-149.

PMID: 36812097 PMC: 9937449. DOI: 10.20517/evcna.2022.14.

References

Vazeux R, Brousse N, Jarry A, Henin D, Marche C, VEDRENNE C . AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol. 1987; 126(3):403-10. PMC: 1899654. View

Christensen B, Fink J, MERRIFIELD R, Mauzerall D . Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci U S A. 1988; 85(14):5072-6. PMC: 281690. DOI: 10.1073/pnas.85.14.5072. View

Ohe Y, Hayashi H, Iwai K . Human spleen histone H1. Isolation and amino acid sequence of a main variant, H1b. J Biochem. 1986; 100(2):359-68. DOI: 10.1093/oxfordjournals.jbchem.a121722. View

Ensoli B, Barillari G, Salahuddin S, Gallo R, Wong-Staal F . Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990; 345(6270):84-6. DOI: 10.1038/345084a0. View

Benko D, Schwartz S, Pavlakis G, Felber B . A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol. 1990; 64(6):2505-18. PMC: 249426. DOI: 10.1128/JVI.64.6.2505-2518.1990. View

Siomi H, Shida H, Nam S, Nosaka T, Maki M, Hatanaka M . Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell. 1988; 55(2):197-209. DOI: 10.1016/0092-8674(88)90043-8. View

Narahashi T . Chemicals as tools in the study of excitable membranes. Physiol Rev. 1974; 54(4):813-89. DOI: 10.1152/physrev.1974.54.4.813. View

Haase A . Pathogenesis of lentivirus infections. Nature. 1986; 322(6075):130-6. DOI: 10.1038/322130a0. View

Letvin N, Daniel M, Sehgal P, Desrosiers R, Hunt R, Waldron L . Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science. 1985; 230(4721):71-3. DOI: 10.1126/science.2412295. View

10.

Duval A, Malecot C, Pelhate M, Rochat H . Changes in Na channel properties of frog and rat skeletal muscles induced by the AaH II toxin from the scorpion Androctonus australis. Pflugers Arch. 1989; 415(3):361-71. DOI: 10.1007/BF00370889. View

11.

Viscidi R, Mayur K, Lederman H, Frankel A . Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science. 1989; 246(4937):1606-8. DOI: 10.1126/science.2556795. View

12.

HAUBER J, Malim M, Cullen B . Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol. 1989; 63(3):1181-7. PMC: 247813. DOI: 10.1128/JVI.63.3.1181-1187.1989. View

13.

Green M, Ishino M, Loewenstein P . Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell. 1989; 58(1):215-23. DOI: 10.1016/0092-8674(89)90417-0. View

14.

Eilbott D, Peress N, Burger H, LaNeve D, Orenstein J, Gendelman H . Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc Natl Acad Sci U S A. 1989; 86(9):3337-41. PMC: 287127. DOI: 10.1073/pnas.86.9.3337. View

15.

Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P . The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988; 239(4840):586-92. DOI: 10.1126/science.3277272. View

16.

Kordel M, Benz R, Sahl H . Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol. 1988; 170(1):84-8. PMC: 210609. DOI: 10.1128/jb.170.1.84-88.1988. View

17.

Zasloff M . Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987; 84(15):5449-53. PMC: 298875. DOI: 10.1073/pnas.84.15.5449. View

18.

Sabatier J, Fontan G, Loret E, Mabrouk K, Rochat H, Gluckman J . Large fragments of nef-protein and gp110 envelope glycoprotein from HIV-1. Synthesis, CD analysis and immunoreactivity. Int J Pept Protein Res. 1990; 35(1):63-72. DOI: 10.1111/j.1399-3011.1990.tb00722.x. View

19.

Dreyer E, Kaiser P, Offermann J, Lipton S . HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990; 248(4953):364-7. DOI: 10.1126/science.2326646. View

20.

Harrow I, Hue B, Pelhate M, Sattelle D . Cockroach giant interneurones stained by cobalt-backfilling of dissected axons. J Exp Biol. 1980; 84:341-3. DOI: 10.1242/jeb.84.1.341. View